PEH–s Portfolio Company Enanta announces U.S. FDA Approval for AbbVie–s VIEKIRA PAK(TM)

Private Equity Holding AG /
PEH–s Portfolio Company Enanta announces U.S. FDA Approval for AbbVie–s VIEKIRA
PAK(TM)
. Verarbeitet und übermittelt durch NASDAQ OMX Corporate Solutions.
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.
Source: Globenewswire

Zug, December 22, 2014
Enanta Pharmaceutical Inc., (NASDAQ: ENTA) a research and development-focused
biotechnology company dedicated to creating small molecule drugs primarily in
the infectious disease field is Private Equity Holding AG–s largest direct
investment. Enanta has announced that the U.S. Food and Drug Administration has
approved AbbVie–s VIEKIRA PAK(TM) for the Treatment of Chronic Genotype 1
Hepatitis C Virus.
The VIEKIRA PAK regimen contains Enanta–s lead protease inhibitor paritaprevir
(formerly ABT-450) and cured 95-100 percent of Hepatitis C patients, with less
than two percent of patients experiencing virological failure in Phase 3
clinical trials. For more information, please refer to
http://ir.enanta.com/phoenix.zhtml?c=147990&p=irol-newsArticle&ID=2001257.
PEH had invested in Enanta in 1999 as part of the original shareholder syndicate
and backed the current management team through a strategic reorientation of the
business in 2002. PEH participated in several financing rounds thereafter and
the initial public offering in 2013 – all of which has created very significant
value for PEH–s shareholders to date.

***

Private Equity Holding AG (SIX: PEHN) offers investors the opportunity to
invest, within a simple legal and tax optimized structure, in a broadly
diversified and professionally managed private equity portfolio.
For further information, please contact:
Emanuel Eftimiu, Investor Relations, emanuel.eftimiu@peh.ch, phone
+41 41 726 79 80, http://www.peh.ch

PEH_PR_141222:
http://hugin.info/130308/R/1882491/664144.pdf

This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Private Equity Holding AG via GlobeNewswire
[HUG#1882491]